12:00 AM
 | 
Dec 14, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Clonidine ER Tablets regulatory update

FDA approved a pair of NDAs from Tris for Clonidine ER Suspension and Clonidine ER Tablets to treat hypertension. The once-daily...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >